Skip to main content

Table 3 Multivariable-adjusted association between sleep duration and incidence of cognitive impairment

From: Dietary amino acid intake and sleep duration are additively involved in future cognitive decline in Japanese adults aged 60 years or over: a community-based longitudinal study

 

Crude

Model 1

Model 2

Group of sleep duration*

OR

95%CI

P value

OR

95%CI

P value

OR

95%CI

P value

Short sleep

0.82

0.50–1.35

0.427

0.79

0.48–1.32

0.376

0.81

0.49–1.35

0.423

Moderate sleep

Ref.

  

Ref.

  

Ref.

  

Long sleep

1.58

1.22–2.06

0.001

1.41

1.07–1.87

0.016

1.41

1.05–1.87

0.020

  1. *Sleep duration is calculated over 24 h. Short sleep was defined as sleep duration ≤ 6 h, moderate sleep was defined as sleep duration of 7–8 h, and long sleep was defined as sleep duration > 8 h
  2. ORs and 95% CIs were estimated using the generalized estimating equations
  3. Model 1: adjusted for sex, age (60–69 y/70–79 y/≥80 y), BMI (kg/m²), MMSE (score), CES-D (score), education (0–7 y/8–15 y/≥16 y), smoking status (current/not), employment status (yes/no), use of hypnotics, sedatives, or anxiolytics (yes/no), physical activity (MET-min/d) at baseline, and follow-up period (y)
  4. Model 2: adjusted for history of stroke, hypertension, ischemic heart disease, dyslipidemia, and diabetes mellitus, in addition to the variables in Model 1
  5. OR, odds ratio; CI, confidence interval; Ref., reference; BMI, body mass index; MMSE, Mini-Mental State Examination; CES-D, Center for Epidemiologic Studies Depression Scale; MET, metabolic equivalents